Deep vein thrombosis - Myeloproliferative disease Factor
Last reviewed for CCPS 22 December 2008.
Preliminary questions [21252]
25112 there is some evidence that a myeloproliferative disease may be a factor in the development of the condition under consideration.
21435 the veteran has had a myeloproliferative disease at some time.
21436 — myeloproliferative disease means a family of disorders, including polycythaemia vera, idiopathic myelofibrosis and essential thrombocytosis, characterised by increased blood cell production which arise in a clonal manner from abnormalities at the level of the haematopoietic stem cell. [Default true]
21437 the veteran had the identified illness or injury, a myeloproliferative disease, at the time of the clinical onset of the condition under consideration.
21438 — the veteran has established the causal connection between the myeloproliferative disease and VEA service for the clinical onset of deep vein thrombosis.
21439 — the veteran has established the causal connection between the myeloproliferative disease and operational service for the clinical onset of deep vein thrombosis.
or
21440 — the veteran has established the causal connection between the myeloproliferative disease and eligible service for the clinical onset of deep vein thrombosis.
Clinical onset and operational service [21439]
21441 — the identified illness or injury, a myeloproliferative disease, is causally related to operational service.
Clinical onset and eligible service [21440]
21442 — the identified illness or injury, a myeloproliferative disease, is causally related to eligible service.